GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (STU:0NF0) » Definitions » Institutional Ownership

Mydecine Innovations Group (STU:0NF0) Institutional Ownership : 0.24% (As of May. 16, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Mydecine Innovations Group Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Mydecine Innovations Group's institutional ownership is 0.24%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Mydecine Innovations Group's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Mydecine Innovations Group's Float Percentage Of Total Shares Outstanding is 0.00%.


Mydecine Innovations Group Institutional Ownership Historical Data

The historical data trend for Mydecine Innovations Group's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Institutional Ownership Chart

Mydecine Innovations Group Historical Data

The historical data trend for Mydecine Innovations Group can be seen below:

2021-08-31 2021-09-30 2021-10-31 2021-11-30 2021-12-31 2022-01-31 2022-02-28 2022-03-31 2022-04-30 2022-05-31
Institutional Ownership 2.16 2.38 2.41 2.42 1.63 1.56 1.52 0.47 0.25 0.24

Mydecine Innovations Group Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Mydecine Innovations Group (STU:0NF0) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group (STU:0NF0) Headlines

No Headlines